| An integrated map of genetic variation from 1,092 human genomes 1000 Genomes Project Consortium Nature 491 (7422), 56, 2012 | 8326 | 2012 |
| Patterns and rates of exonic de novo mutations in autism spectrum disorders BM Neale, Y Kou, L Liu, A Ma’Ayan, KE Samocha, A Sabo, CF Lin, ... Nature 485 (7397), 242-245, 2012 | 2043 | 2012 |
| De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability SE McCarthy, J Gillis, M Kramer, J Lihm, S Yoon, Y Berstein, M Mistry, ... Molecular psychiatry 19 (6), 652-658, 2014 | 406 | 2014 |
| Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer LA Rojas, Z Sethna, KC Soares, C Olcese, N Pang, E Patterson, J Lihm, ... Nature 618 (7963), 144-150, 2023 | 393 | 2023 |
| Neoantigen quality predicts immunoediting in survivors of pancreatic cancer M Łuksza, ZM Sethna, LA Rojas, J Lihm, B Bravi, Y Elhanati, K Soares, ... Nature 606 (7913), 389-395, 2022 | 117 | 2022 |
| AnnTools: a comprehensive and versatile annotation toolkit for genomic variants V Makarov, T O'Grady, G Cai, J Lihm, JD Buxbaum, S Yoon Bioinformatics 28 (5), 724-725, 2012 | 61 | 2012 |
| Rare disruptive variants in the DISC1 Interactome and Regulome: association with cognitive ability and schizophrenia S Teng, PA Thomson, S McCarthy, M Kramer, S Muller, J Lihm, S Morris, ... Molecular psychiatry 23 (5), 1270-1277, 2018 | 46 | 2018 |
| Systemic and oligo-acquired resistance to PD-(L) 1 blockade in lung cancer AJ Schoenfeld, HA Rizvi, D Memon, N Shaverdian, MJ Bott, JL Sauter, ... Clinical Cancer Research 28 (17), 3797-3803, 2022 | 25 | 2022 |
| DNA sequence-level analyses reveal potential phenotypic modifiers in a large family with psychiatric disorders NM Ryan, J Lihm, M Kramer, S McCarthy, SW Morris, A Arnau-Soler, ... Molecular psychiatry 23 (12), 2254-2265, 2018 | 18 | 2018 |
| Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer D Memon, AJ Schoenfeld, D Ye, G Fromm, H Rizvi, X Zhang, MR Keddar, ... Cancer Cell 42 (2), 209-224. e9, 2024 | 10 | 2024 |
| Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer. M Lattanzi, A Solovyov, J Lihm, C Quinlan, K Whiting, H Li, ... Journal of Clinical Oncology 40 (16_suppl), 4584-4584, 2022 | 1 | 2022 |
| 824 High quality neoantigens are immunoedited in long-term pancreatic cancer survivors Z Sethna, M Luksza, L Rojas, K Soares, J Leung, J Lihm, D Hoyos, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 1 | 2021 |
| Beyond the translocation: whole genome sequencing analysis of the Scottish t (1; 11) family N Ryan, J Lihm, M Kramer, S McCarthy, K Evans, E Ghiban, JK Millar, ... European Neuropsychopharmacology 29, S890, 2019 | 1 | 2019 |
| Modeling tumor immunoediting under immune selective pressure to inform neoantigen landscape dynamics for effective cancer vaccines MM George, J Lihm, H Choi, Y Elhanati, S Martis, M Luksza, ... Cancer Research 84 (6_Supplement), 4093-4093, 2024 | | 2024 |
| Rapid autopsy reveals the interplay of tumor heterogeneity at genomic, transcriptomic, and spatial dimensions N Yao, R Vanguri, J Patel, J Lihm, A Fisher, I Jarchum, S Umeda, H Li, ... Cancer Research 84 (6_Supplement), 6243-6243, 2024 | | 2024 |
| Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer MR Keddar, D Mathew, KJ Yoo, J Qiu, J Lihm, J Miriyala, JL Sauter, J Luo, ... Cancer Cell 42, 1-16, 2024 | | 2024 |
| The dynamics of LINE-1 retrotransposition in cellular populations S Martis, A Solovyov, J Lihm, H Li, B Greenbaum Cancer Research 83 (7_Supplement), 860-860, 2023 | | 2023 |
| Modeling tumor immunoediting coupled with T-cell repertoire dynamic J Lihm, H Choi, MM George, Y Elhanati, D Hoyos, M Luksza, T Merghoub, ... Cancer Research 83 (7_Supplement), 610-610, 2023 | | 2023 |
| Correlating HLA variants and the emergence of immune-related adverse events (irAEs) from ipilimumab/nivolumab (I/N) in patients (pts) treated on CheckMate 214. MH Voss, NJ Shah, HL Kalvin, J Lihm, H Li, RR Kotecha, I Jarchum, ... Journal of Clinical Oncology 41 (6_suppl), 659-659, 2023 | | 2023 |
| Abstract PR-003: High quality neoantigens are immunoedited in long-term pancreatic cancer survivors LA Rojas, M Łuksza, ZM Sethna, K Soares, J Leung, J Lihm, D Hoyos, ... Cancer Research 81 (22_Supplement), PR-003-PR-003, 2021 | | 2021 |
